Recruiting
Phase 1

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05276973

Conditions

Fallopian Tube Endometrioid Adenocarcinoma

Fallopian Tube High Grade Serous Adenocarcinoma

Ovarian Endometrioid Adenocarcinoma

Ovarian High Grade Serous Adenocarcinoma

Primary Peritoneal Endometrioid Adenocarcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Carboplatin

Ipatasertib

Paclitaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information